Brief: AFT Pharmaceuticals Says FDA Allows Injectable Iron Project Clinical Study
24/06/2026 02:17
BRIEF-AFT Pharmaceuticals Says FDA Allows Injectable Iron Project Clinical Study June 24 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ:
FDA ALLOWS AFT'S INJECTABLE IRON PROJECT CLINICAL STUDY
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV